Title
Association of Ideal Cardiovascular Health With Vascular Brain Injury and Incident Dementia
Date Issued
01 May 2016
Access level
open access
Resource Type
journal article
Author(s)
Pase M.P.
Beiser A.
Enserro D.
Xanthakis V.
Aparicio H.
Satizabal C.L.
Himali J.J.
Kase C.S.
Vasan R.S.
DeCarli C.
Seshadri S.
Publisher(s)
Lippincott Williams and Wilkins
Abstract
Background and Purpose - The American Heart Association developed the ideal cardiovascular health (CVH) index as a simple tool to promote CVH; yet, its association with brain atrophy and dementia remains unexamined. Methods - Our aim was to investigate the prospective association of ideal CVH with vascular brain injury, including the 10-year risks of incident stroke and dementia, as well as cognitive decline and brain atrophy on magnetic resonance imaging, measured for ≈7 years. We studied 2750 stroke- and dementia-free Framingham Heart Study Offspring cohort participants (mean age, 62±9 years; 45% men). Ideal CVH was quantified on a 7-point scale with 1 point awarded for each of the following: nonsmoking status, ideal body mass index, regular physical activity, healthy diet, as well as optimum blood pressure, cholesterol, and fasting blood glucose. Both recent (baseline) and remote (6.9 years earlier) ideal CVH scores were examined. Results - Recent ideal CVH was associated with stroke (hazard ratio, 0.80; 95% confidence interval, 0.67-0.95), vascular dementia (hazard ratio, 0.49; 95% confidence interval, 0.30-0.81), frontal brain atrophy (P=0.003), and cognitive decline on tasks measuring visual memory and reasoning (P<0.05). In addition to predicting stroke, vascular dementia, whole-brain atrophy, and cognitive decline, remote ideal CVH was associated with the incidence of all-cause dementia (hazard ratio, 0.80; 95% confidence interval, 0.67-0.97) and Alzheimer disease (hazard ratio, 0.79; 95% confidence interval, 0.64-0.98). Conclusions - Adherence to the American Heart Association's ideal CVH factors and behaviors, particularly in midlife, may protect against cerebrovascular disease and dementia.
Start page
1201
End page
1206
Volume
47
Issue
5
Language
English
Subjects
Scopus EID
2-s2.0-84963700328
PubMed ID
Source
Stroke
ISSN of the container
00392499
Sponsor(s)
Dr Pase was funded by an Australian National Health and Medical Research Council Early Career Fellowship (APP1089698), and his work on stroke was funded by a Rebecca L Cooper Medical Research Foundation grant. The Framingham Heart Study was supported by the National Heart, Lung and Blood Institute Framingham Heart Study (contracts, N01-HC-25195 and HHSN268201500001I) and grants from the National Institute of Neurological Disorders and Stroke (NS17950) and the National Institute of Aging (AG08122, AG033193, and AG049607). Dr DeCarli directs the UC Davis Alzheimer's Disease Center with funding from the National Institutes of Health (P30 AG010182).
Sources of information:
Directorio de Producción CientÃfica
Scopus